Hypolipidemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used in the treatment of high levels of fats (lipids), such as cholesterol, in the blood (hyperlipidemia). They are called lipid-lowering drugs . The sites of action of several antihyperlipidemic drugs are shown. .. on LDL cholesterol, they are often combined with other antilipidemic drugs for treatment of. Antihyperlipidemic Drugs Dr Ahmed Bader Faculty of Medicine, Menoufiya University, Egypt.
|Published (Last):||23 December 2012|
|PDF File Size:||8.58 Mb|
|ePub File Size:||9.94 Mb|
|Price:||Free* [*Free Regsitration Required]|
We comply with the HONcode standard for trustworthy health information – verify here. Retrieved from ” https: The drugs are more potent than traditional cholesterol-lowering statin drugs, such as Pfizer Inc’s Lipitor. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Antihyperlipidemic agents What are Antihyperlipidemic agents?
Macrophages in arterial walls use scavenger receptors to take up circulating lipoproteins, especially particles with apolipoproteins that have been modified by free radicals. Another lipoprotein, high-density lipoprotein HDLexerts several antiatherogenic effects.
The companies are conducting cardiovascular outcomes trials to determine whether their ability to dramatically lower bad LDL cholesterol will lead to fewer heart attacks, strokes and deaths. Repatha was approved to treat patients with heterozygous familial hypercholesterolemia HeFH and patients with the rarer homozygous HoFH form of the disease.
They are called lipid-lowering drugs.
Hypolipidemic agentsor antihyperlipidemic agentsare a diverse group of pharmaceuticals that are used in the treatment of high levels of fats lipidssuch as cholesterol, in the blood hyperlipidemia. Whereas plaques can slowly occlude coronary and cerebral vessels, clinical symptoms are more frequently precipitated by rupture of unstable plaques, leading to occlusive thrombi. The promising clinical results of several novel drug candidates, particularly for LDL cholesterol lowering with monoclonal antibodies raised against PCSK9, may indicate more than a decade after the statins, the entrance of new breakthrough therapies to treat lipid disorders.
The product will be available next week. By reducing the LDL cholesterol, they can prevent both the primary and secondary symptoms of coronary heart disease. If your institution subscribes to this resource, and you don’t have a MyAccess Profile, please contact your library’s reference desk for information on how to gain access to this resource from off-campus. Antihyperlipidemic agents promote reduction of lipid levels in the blood.
Decongestants Bronchodilators Cough medicines H 1 antagonists. Besides small molecules for novel targets, biological drugs such as monoclonal antibodies, antisense or gene-silencing oligonucleotides, peptidomimetics, reconstituted synthetic HDL particles and therapeutic proteins are novel approaches in clinical development are which have to be applied by injection or infusion. Consequently, the search for novel lipid-modifying drugs is still one of the most active areas in research and development in the pharmaceutical industry.
HDL participates in pathways that retrieve cholesterol from the artery wall and inhibit the oxidation of atherogenic lipoproteins. Sign up for our email newsletter.
Anticancer agents Antimetabolites Alkylating Spindle poisons Antineoplastic Topoisomerase inhibitors. Please enter User Name Password Error: The uptake by cells of B—containing lipoproteins can occur by receptor-mediated endocytosis or by scavenger receptors. Clinically, the choice of an agent will depend on the patient’s cholesterol profilecardiovascular riskand the liver and kidney functions of the patient, evaluated against the balancing of risks and benefits of the medications. Use this site remotely Bookmark your favorite content Track your self-assessment progress and more!
Jump antilipidemoc a Section Antihyperlipidemic Drugs: America’s Health Insurance Plans, the industry trade group, has protested the high price of Praluent, saying it has concerns about the health system’s ability to sustain the long-term costs.
Antilipidemic Drug Therapy Today and in the Future.
By clicking Subscribe, I agree to the Drugs. The treatment of ddrugs disorders was revolutionized with the introduction of statins which have become the most important therapeutic option available today to reduce and prevent drrugs and its detrimental consequences like cardiovascular diseases and stroke. Types of Antihyperlipidemic agents Please refer to the drug classes listed below for further information. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some antihyperlipidemic agents aim to lower the levels of low-density lipoprotein LDL cholesterol, some reduce triglyceride levels, and some help raise the high-density lipoprotein HDL cholesterol. Subscribe to free Drugs. Please enter Password Forgot Username? Sign in via Shibboleth.
List of Antihyperlipidemic agents – Generics Only –
Praluent is given every other week by injection in doses of 75 mg or mg. It was also approved for patients with cardiovascular disease including heart attack or stroke, who require additional cholesterol lowering.
But it is not yet known whether their cholesterol-lowering power will translate into a reduced number of heart attacks. In other projects Wikimedia Commons.